Opaleye Management Inc.
SEC CIK 1595855 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GRCE | Grace Therapeutics, Inc. | 10% | 2.86M | $87.8K | — | 3 | 2026-08-14 | 2026-09-21 |
| ACOG | Alpha Cognition Inc. | 10% | 3.17M | $7.22M | — | 21 | 2026-02-20 | 2026-09-14 |
| SLGL | Sol-Gel Technologies Ltd. | 10% | 540.0K | $11.23M | — | 25 | 2025-11-20 | 2026-09-10 |
| ETON | Eton Pharmaceuticals, Inc. | 10% | 40.0K | $1.14M | $14.13M | 13 | 2021-08-04 | 2026-07-14 |
| SNWV | SANUWAVE Health, Inc. | 10% | 5,000 | $681.2K | $2.19M | 6 | 2024-10-30 | 2026-04-30 |
| HROW | HARROW, INC. | 10% | 3.76M | $8.52M | $12.09M | 26 | 2021-07-19 | 2026-03-03 |
| CDXS | CODEXIS, INC. | 10% | 180.0K | $13.73M | $2.59M | 28 | 2024-09-18 | 2025-11-26 |
| TARA | Protara Therapeutics, Inc. | 10% | 51.5K | $918.6K | $1.71M | 22 | 2021-11-04 | 2024-09-11 |
| TELA | TELA Bio, Inc. | 10% | 124.8K | $3.99M | — | 18 | 2022-06-10 | 2022-11-03 |
Most active insiders at GRCE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kohli Prashant | CEO, Dir | $214.0K | — |
| 2 | Opaleye Management Inc. | 10% | $87.8K | — |
Transactions 162
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-09-19 | 2024-09-18 | CDXS | CODEXIS, INC. | Opaleye Management Inc. | 10% | P - Purchase | $3.16 | +61.0K | 205.0K | +42% | +$192.8K |
| MI | 2024-09-12 | 2024-09-10+ | ETON | Eton Pharmaceuticals, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $4.70 | +107.5K | 70.0K | New | +$504.9K |
| MI | 2024-09-12 | 2024-09-11+ | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% | S - Sale | $1.71 | -158.9K | 51.5K | -76% | -$271.7K |
| MI | 2024-09-10 | 2024-09-09+ | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% | S - Sale | $1.84 | -62.0K | 53.1K | -54% | -$114.1K |
| MI | 2024-07-18 | 2024-07-16 | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% | S - Sale | $2.44 | -11.4K | 56.5K | -17% | -$27.8K |
| MI | 2024-07-11 | 2024-07-09+ | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% | S - Sale | $2.36 | -74.6K | 60.0K | -55% | -$175.7K |
| MI | 2024-07-03 | 2024-07-01 | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% | S - Sale | $2.12 | -8,288 | 87.5K | -9% | -$17.6K |
| MI | 2024-06-28 | 2024-06-27+ | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% | S - Sale | $2.21 | -64.6K | 2.23M | -3% | -$142.5K |
| MI | 2024-06-27 | 2024-06-25 | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% | S - Sale | $2.26 | -12.7K | 102.5K | -11% | -$28.8K |
| MI | 2024-05-31 | 2024-05-30+ | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% | S - Sale | $2.92 | -15.1K | 108.7K | -12% | -$44.0K |
| MI | 2024-05-23 | 2024-05-21+ | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% | S - Sale | $3.05 | -42.8K | 124.2K | -26% | -$130.6K |
| MI | 2024-05-17 | 2024-05-17 | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% | S - Sale | $3.25 | -70.9K | 2.31M | -3% | -$230.4K |
| MI | 2024-05-10 | 2024-05-09+ | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% | S - Sale | $3.11 | -182.3K | 2.38M | -7% | -$566.3K |
| I | 2024-04-25 | 2024-04-25 | HROW | HARROW, INC. | Opaleye Management Inc. | 10% | P - Purchase | $9.97 | +20.0K | 3.81M | +0.5% | +$199.4K |
| MI | 2024-04-24 | 2024-04-23+ | HROW | HARROW, INC. | Opaleye Management Inc. | 10% | P - Purchase | $10.23 | +20.0K | 3.79M | +0.5% | +$204.6K |
| I | 2024-04-19 | 2024-04-19 | HROW | HARROW, INC. | Opaleye Management Inc. | 10% | P - Purchase | $10.56 | +29.4K | 3.77M | +0.8% | +$310.5K |
| I | 2024-03-28 | 2024-03-28 | HROW | HARROW, INC. | Opaleye Management Inc. | 10% | P - Purchase | $12.82 | +50.0K | 3.75M | +1% | +$641.0K |
| I | 2024-03-22 | 2024-03-20 | HROW | HARROW, INC. | Opaleye Management Inc. | 10% | P - Purchase | $9.65 | +50.6K | 3.70M | +1% | +$488.3K |
| I | 2023-11-16 | 2023-11-15 | HROW | HARROW, INC. | Opaleye Management Inc. | 10% | P - Purchase | $8.03 | +25.0K | 3.65M | +0.7% | +$200.7K |
| MI | 2023-09-20 | 2023-09-19+ | HROW | HARROW, INC. | Opaleye Management Inc. | 10% | P - Purchase | $14.60 | +20.0K | 3.62M | +0.6% | +$292.0K |
| MI | 2022-12-30 | 2022-12-30 | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% | S - Sale | $2.71 | +15.5K | 130.0K | +14% | +$41.9K |
| MI | 2022-12-14 | 2022-12-14 | HROW | HARROW, INC. | Opaleye Management Inc. | 10% | P - Purchase | $10.52 | +431.2K | 175.0K | New | +$4.54M |
| MI | 2022-11-04 | 2022-11-03 | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $7.81 | +20.3K | 124.8K | +19% | +$158.2K |
| MI | 2022-10-11 | 2022-10-11 | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $8.00 | +16.0K | 123.6K | +15% | +$128.0K |
| MI | 2022-09-30 | 2022-09-28 | HROW | HARROW, INC. | Opaleye Management Inc. | 10% | P - Purchase | $9.77 | +11.1K | 158.8K | +8% | +$108.3K |
| MI | 2022-09-26 | 2022-09-23 | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $7.99 | +6,804 | 1.91M | +0.4% | +$54.4K |
| MI | 2022-09-19 | 2022-09-19 | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $8.09 | +18.0K | 122.2K | +17% | +$145.6K |
| MI | 2022-09-16 | 2022-09-15+ | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $8.09 | +6,530 | 120.9K | +6% | +$52.8K |
| MI | 2022-09-15 | 2022-08-16 | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $8.10 | +5,221 | 120.2K | +5% | +$42.3K |
| MI | 2022-09-15 | 2022-09-14+ | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $3.93 | +23.9K | 2.58M | +0.9% | +$93.8K |
| MI | 2022-08-16 | 2022-08-16 | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $8.00 | +315.0K | 120.0K | New | +$2.52M |
| MI | 2022-08-12 | 2022-08-10 | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $8.52 | +12.0K | 1.58M | +0.8% | +$102.1K |
| MAI | 2022-08-12 | 2022-08-01 | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $7.96 | +4,979 | 1.57M | +0.3% | +$39.6K |
| MI | 2022-08-02 | 2022-08-01 | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $7.96 | +4,979 | 1.57M | +0.3% | +$39.6K |
| MI | 2022-07-22 | 2022-07-22 | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $8.02 | +5,200 | 100.2K | +5% | +$41.7K |
| MI | 2022-07-21 | 2022-07-21 | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $8.03 | +10.3K | 100.0K | +12% | +$83.0K |
| MI | 2022-07-20 | 2022-07-20 | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $8.08 | +5,100 | 1.55M | +0.3% | +$41.2K |
| I | 2022-07-05 | 2022-07-01 | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $7.00 | +200 | 98.6K | +0.2% | +$1,400 |
| MI | 2022-06-30 | 2022-06-29+ | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $7.00 | +3,567 | 1.54M | +0.2% | +$25.0K |
| MI | 2022-06-24 | 2022-06-22 | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $6.99 | +2,400 | 1.54M | +0.2% | +$16.8K |
| MI | 2022-06-22 | 2022-06-10+ | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $6.50 | +52.4K | 1.54M | +4% | +$340.6K |
| MI | 2022-06-10 | 2022-06-10 | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $5.60 | +27.5K | 95.0K | +41% | +$154.0K |
| MAI | 2022-04-15 | 2022-04-07+ | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $4.79 | +10.1K | 125.0K | +9% | +$48.5K |
| MI | 2022-04-13 | 2022-04-12+ | HROW | HARROW, INC. | Opaleye Management Inc. | 10% | P - Purchase | $6.75 | +41.4K | 3.17M | +1% | +$279.5K |
| MI | 2022-04-08 | 2022-04-07+ | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $4.79 | +10.1K | 125.0K | +9% | +$48.5K |
| MI | 2022-01-31 | 2022-01-28 | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $4.96 | +24.0K | 2.55M | +1.0% | +$119.2K |
| MI | 2022-01-31 | 2022-01-28 | HROW | HARROW, INC. | Opaleye Management Inc. | 10% | P - Purchase | $6.89 | +6,343 | 150.0K | +4% | +$43.7K |
| MI | 2021-12-29 | 2021-12-28+ | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $6.60 | +11.6K | 2.53M | +0.5% | +$76.5K |
| MI | 2021-12-27 | 2021-12-23+ | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $6.53 | +38.0K | 105.0K | +57% | +$248.2K |
| I | 2021-12-22 | 2021-12-20 | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $6.49 | +703 | 2.50M | +0.0% | +$4,562 |
| MI | 2021-12-20 | 2021-12-16+ | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $6.46 | +10.4K | 2.50M | +0.4% | +$66.9K |
| I | 2021-11-19 | 2021-11-17 | ETON | Eton Pharmaceuticals, Inc. | Opaleye Management Inc. | 10% | S - Sale | $4.67 | -25.0K | 2.38M | -1% | -$116.8K |
| MI | 2021-11-19 | 2021-11-17+ | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $6.98 | +24.3K | 2.47M | +1.0% | +$169.8K |
| MI | 2021-11-17 | 2021-11-15+ | ETON | Eton Pharmaceuticals, Inc. | Opaleye Management Inc. | 10% | S - Sale | $4.85 | -15.4K | 2.40M | -0.6% | -$74.8K |
| MI | 2021-11-09 | 2021-11-05+ | ETON | Eton Pharmaceuticals, Inc. | Opaleye Management Inc. | 10% | S - Sale | $6.25 | -220.4K | 86.4K | -72% | -$1.38M |
| MI | 2021-11-08 | 2021-11-04 | TARA | Protara Therapeutics, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $6.50 | +6,557 | 2.46M | +0.3% | +$42.6K |
| MI | 2021-11-05 | 2021-11-03+ | ETON | Eton Pharmaceuticals, Inc. | Opaleye Management Inc. | 10% | S - Sale | $6.49 | -202.2K | 2.62M | -7% | -$1.31M |
| MI | 2021-10-13 | 2021-10-08+ | ETON | Eton Pharmaceuticals, Inc. | Opaleye Management Inc. | 10% | S - Sale | $5.03 | -165.1K | 112.8K | -59% | -$831.1K |
| MI | 2021-08-23 | 2021-08-19 | HROW | HARROW, INC. | Opaleye Management Inc. | 10% | P - Purchase | $8.45 | +52.5K | 3.13M | +2% | +$443.6K |
| MI | 2021-08-19 | 2021-08-17+ | HROW | HARROW, INC. | Opaleye Management Inc. | 10% | P - Purchase | $8.61 | +72.5K | 146.0K | +99% | +$624.6K |
| MI | 2021-08-06 | 2021-08-04+ | ETON | Eton Pharmaceuticals, Inc. | Opaleye Management Inc. | 10% | S - Sale | $5.83 | -604.5K | 132.1K | -82% | -$3.52M |
| MI | 2021-07-22 | 2021-07-19+ | HROW | HARROW, INC. | Opaleye Management Inc. | 10% | P - Purchase | $7.32 | +20.0K | 140.3K | +17% | +$146.3K |
Purchase Sale Sale after option exercise All abbreviations